| ［1］ |
铁·杜尔娜, 左亚刚. 类天疱疮致病性抗体与免疫吸附［J］. 临床皮肤科杂志, 2015,44（4）:264⁃267. doi: 10.16761/j.cnki.1000⁃4963.2015.04.036.
|
| ［2］ |
Ujiie H, Yoshimoto N, Natsuga K, et al. Immune reaction to type XVII collagen induces intramolecular and intermolecular epitope spreading in experimental bullous pemphigoid models［J］. Front Immunol, 2019,10:1410. doi: 10.3389/fimmu.2019. 01410.
|
| ［3］ |
Hashimoto T, Tsuruta D, Dainichi T, et al. Demonstration of epitope spreading in bullous pemphigoid: results of a prospective multicenter study［J］. J Invest Dermatol, 2011,131（11）:2175⁃2177. doi: 10.1038/jid.2011.276.
|
| ［4］ |
Seo T, Ujiie H, Ujiie I, et al. Epitope spreading possibly from BP230 to the NC16A domain of BP180 preceding disease progression in bullous pemphigoid［J］. J Dermatol, 2020,47（7）:e255⁃e257. doi: 10.1111/1346⁃8138.15362.
|
| ［5］ |
Didona D, Di Zenzo G. Humoral epitope spreading in autoimmune bullous diseases［J］. Front Immunol, 2018,9:779. doi: 10.3389/fimmu.2018.00779.
|
| ［6］ |
Fairley JA, Woodley DT, Chen M, et al. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading［J］. J Am Acad Dermatol, 2004,51（1）:118⁃122. doi: 10.1016/j.jaad.2003.12.033.
|
| ［7］ |
Kasperkiewicz M, Hoppe U, Zillikens D, et al. Relapse⁃associated autoantibodies to BP180 in a patient with anti⁃p200 pemphigoid［J］. Clin Exp Dermatol, 2010,35（6）:614⁃617. doi: 10.1111/j.1365⁃2230.2009.03731.x.
|
| ［8］ |
Li Y, Foshee JB, Sontheimer RD. Sustained clinical response to rituximab in a case of life⁃threatening overlap subepidermal autoimmune blistering disease［J］. J Am Acad Dermatol, 2011, 64（4）: 773⁃778. doi: 10.1016/j.jaad.2009.09.045.
|
| ［9］ |
Wald A, Schmidt E, Toberer F, et al. Overlap of bullous, anti⁃laminin⁃332, and anti⁃p200 pemphigoid with concomitant anti⁃contactin⁃1⁃positive inflammatory polyneuropathy treated with intravenous immunoglobulins as a manifestation of epitope spreading［J］. JAMA Dermatol, 2019,155（5）:631⁃633. doi: 10. 1001/jamadermatol.2018.5536.
|
| ［10］ |
Hasegawa A, Shinkuma S, Katsumi T, et al. Localized bullous pemphigoid recurring at different sites: two case reports［J］. Eur J Dermatol, 2020. doi: 10.1684/ejd.2019.3672.
|
| ［11］ |
Zhou S, Zou Y, Pan M. Brunsting⁃Perry pemphigoid transitioning from previous bullous pemphigoid［J］. JAAD Case Rep, 2020,6（3）:192⁃194. doi: 10.1016/j.jdcr.2019.12.018.
|
| ［12］ |
Takama H, Yoshida M, Izumi K, et al. Dipeptidyl peptidase⁃4 Inhibitor⁃associated bullous pemphigoid: recurrence with epitope spreading ［J］. Acta Derm Venereol, 2018,98（10）:983⁃984. doi: 10.2340/00015555⁃3010.
|
| ［13］ |
García⁃Díez I, España A, Iranzo P. Epitope⁃spreading phenomena in dipeptidyl peptidase⁃4 inhibitor⁃associated bullous pemphigoid［J］. Br J Dermatol, 2019, 180（5）: 1267⁃1268. doi: 10.1111/bjd.17690.
|
| ［14］ |
Kodera R, Chiba Y, Tamura Y, et al. Clinical characteristics of bullous pemphigoid in elderly patients with type 2 diabetes mellitus: the association with the use of dipeptidyl peptidase⁃4 inhibitors［J］. Nihon Ronen Igakkai Zasshi, 2019,56（1）:43⁃50. doi: 10.3143/geriatrics.56.43.
|
| ［15］ |
Giusti D, Gatouillat G, Le Jan S, et al. Anti⁃type VII collagen antibodies are identified in a subpopulation of bullous pemphigoid patients with relapse［J］. Front Immunol, 2018, 9:570. doi: 10.3389/fimmu.2018.00570.
|
| ［16］ |
Komai A, Amagai M, Ishii K, et al. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme⁃linked immunosorbent assay［J］. Br J Dermatol, 2001, 144（6）: 1177⁃1182. doi: 10.1046/j.1365⁃2133.2001.04227.x.
|
| ［17］ |
Chapman CM, Kwock J, Cresce N, et al. IgG/IgA pemphigus in a patient with a history of pemphigus vulgaris: an example of epitope spreading?［J］. J Cutan Pathol, 2019,46（5）:380⁃382. doi: 10.1111/cup.13433.
|
| ［18］ |
Tóth GG, Pas HH, Jonkman MF. Transition of pemphigus vulgaris into pemphigus foliaceus confirmed by antidesmoglein ELISA profile［J］. Int J Dermatol, 2002,41（8）:525⁃527. doi: 10. 1046/j.1365⁃4362.2002.15452.x.
|
| ［19］ |
Okahashi K, Oiso N, Ishii N, et al. Paraneoplastic pemphigus associated with Castleman disease: progression from mucous to mucocutaneous lesions with epitope⁃spreading phenomena［J］. Br J Dermatol, 2017,176（5）:1406⁃1409. doi: 10.1111/bjd.15389.
|
| ［20］ |
Recke A, Rose C, Schmidt E, et al. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B⁃cell epitope spreading without IgG subclass shifting［J］. J Am Acad Dermatol, 2009, 61（2）: 333⁃336. doi: 10.1016/j.jaad.2008.10.061.
|
| ［21］ |
Peterson JD, Chang AJ, Chan LS. Clinical evidence of an intermolecular epitope spreading in a patient with pemphigus foliaceus converting into bullous pemphigoid［J］. Arch Dermatol, 2007,143（2）:272⁃274. doi: 10.1001/archderm.143.2.272.
|
| ［22］ |
Schauer F, Steinke H, Thoma K, et al. Transition from bullous pemphigoid to pemphigus foliaceus: intermolecular epitope spreading thirteen years after initial diagnosis［J］. Acta Derm Venereol, 2019, 99（11）: 1029⁃1030. doi: 10.2340/00015555⁃3250.
|
| ［23］ |
Sárdy M, Borovaya A, Horváth ON, et al. Successful rituximab treatment of juvenile bullous pemphigoid with esophageal scarring due to epitope spreading［J］. J Dtsch Dermatol Ges, 2016, 14（6）: 618⁃621. doi: 10.1111/ddg.12902.
|
| ［24］ |
Koga H, Ishii N, Hashimoto T, et al. Case of shift from linear immunoglobulin A bullous dermatosis to pemphigus herpetiformis for a short period of time［J］. J Dermatol, 2017,44（2）:189⁃193. doi: 10.1111/1346⁃8138.13677.
|
| ［25］ |
Boh E, Roberts LJ, Lieu TS, et al. Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus［J］. J Am Acad Dermatol, 1990,22（4）:587⁃593. doi: 10.1016/0190⁃9622（90）70077⁃u.
|
| ［26］ |
Moon SY, Eun DH, Jung HJ, et al. Coexistence of psoriasis and epidermolysis bullosa acquisita: evaluation of the integrity of the basement membrane［J］. J Cutan Pathol, 2017,44（6）:602⁃603. doi: 10.1111/cup.12940.
|
| ［27］ |
Krishnaswamy K, Raju BP, Raveendra L. Epitope spreading phenomenon: a case report［J］. Indian Dermatol Online J, 2019,10（5）:580⁃584. doi: 10.4103/idoj.IDOJ_416_18.
|
| ［28］ |
Zheng J, Liu N, Wang Y, et al. Pemphigus vulgaris with psoriasis vulgaris successfully treated with methotrexate and low⁃dose methylprednisolone ［J］. Dermatol Ther, 2020,33（1）:e13165. doi: 10.1111/dth.13165.
|
| ［29］ |
Balighi K, Daneshpazhooh M, Mahmoudi H, et al. Switching from pemphigus vulgaris to psoriasis: a rare report of three cases ［J］. Int J Dermatol, 2020,59（5）:e144⁃e146. doi: 10.1111/ijd. 14823.
|
| ［30］ |
Mignogna MD, Fortuna G, Leuci S, et al. Lichen planus pemphigoides, a possible example of epitope spreading［J］. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010,109（6）:837⁃843. doi: 10.1016/j.tripleo.2009.12.044.
|
| ［31］ |
Reis Gavazzoni Dias MF, Aparecida Guedes Vilar E, de Oliveira Bento C, et al. Brunsting⁃Perry type pemphigoid causing secondary cicatricial alopecia in 2 patients［J］. Skin Appendage Disord , 2018,4（4）:308⁃311. doi: 10.1159/000485570.
|
| ［32］ |
Huff SB, Vasu S, Kaffenberger BH. Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid resolution with rituximab［J］. Int J Dermatol, 2019,58（2）:240⁃241. doi: 10.1111/ ijd.14027.
|
| ［33］ |
Azizpour A, Nasimi M, Shakoei S, et al. Bullous pemphigoid induced by Hijama therapy （cupping）［J］. Dermatol Pract Concept, 2018,8（3）:163⁃165. doi: 10.5826/dpc.0803a01.
|
